InvestSMART

Regis Healthcare Limited (ASX: REG) - Announcements

Current share price for REG : $6.170 0.05 (0.82%)+

ASX company news and announcements for Regis Healthcare Limited (REG) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Regis Healthcare Limited (REG) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Regis Healthcare Limited (REG), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Regis Healthcare Limited (REG)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$1,866 Regis Healthcare Ltd Investor Presentation 1H FY2023 27 Feb 2023 8:56AM $1.615 $6.170 risen by 282.04%
$1,866 Regis Healthcare Ltd Results Announcement 1H FY2023 27 Feb 2023 8:54AM $1.615 $6.170 risen by 282.04%
$1,866 Regis Healthcare Ltd 4D and Financial Report 1H FY2023 27 Feb 2023 8:52AM $1.615 $6.170 risen by 282.04%
$1,866 Change of FY23 Half Year Results Release Date 1 Feb 2023 3:35PM $1.695 $6.170 risen by 264.01%
$1,866 Notification of Change of Registered Address 30 Jan 2023 11:41AM $1.760 $6.170 risen by 250.57%
$1,866 Notification Of FY23 Half Year Results Release Date 20 Dec 2022 2:30PM $1.975 $6.170 risen by 212.41%
$1,866 Change of Director's Interest Notice 16 Nov 2022 3:33PM $1.960 $6.170 risen by 214.80%
$1,866 Notification regarding unquoted securities - REG 16 Nov 2022 3:29PM $1.950 $6.170 risen by 216.41%
$1,866 Regis Healthcare - Results of Annual General Meeting 25 Oct 2022 4:03PM $1.880 $6.170 risen by 228.19%
$1,866 Chairman and MD Addresses and Presentation to AGM 25 Oct 2022 9:37AM $1.840 $6.170 risen by 235.33%
$1,866 Change Of Director's Interest Notice 28 Sep 2022 9:15AM $1.720 $6.170 risen by 258.72%
$1,866 Application for quotation of securities - REG 27 Sep 2022 4:49PM $1.720 $6.170 risen by 258.72%
$1,866 Notice of Annual General Meeting/Proxy Form 21 Sep 2022 8:48AM $1.800 $6.170 risen by 242.78%
$1,866 Annual Report to shareholders 12 Sep 2022 1:07PM $1.915 $6.170 risen by 222.19%
$1,866 Appendix 4G and Corporate Governance Statement 12 Sep 2022 12:58PM $1.920 $6.170 risen by 221.35%
$1,866 Notification of cessation of securities - REG 30 Aug 2022 12:52PM $2.110 $6.170 risen by 192.42%
$1,866 Regis Healthcare Investor Presentation FY2022 Results 24 Aug 2022 9:04AM $2.040 $6.170 risen by 202.45%
$1,866 Regis Healthcare Results Announcement FY2022 24 Aug 2022 9:02AM $2.040 $6.170 risen by 202.45%
$1,866 Regis Healthcare Appendix 4E and Financial Report FY2022 24 Aug 2022 9:01AM $2.040 $6.170 risen by 202.45%
$1,866 Dividend/Distribution - REG 24 Aug 2022 8:41AM $2.040 $6.170 risen by 202.45%
$1,866 AGM Date 15 Aug 2022 11:08AM $2.280 $6.170 risen by 170.61%
$1,866 Notification of FY22 Full Year Results Date 11 Jul 2022 11:50AM $1.855 $6.170 risen by 232.61%
$1,866 COVID-19 Cost Impacts and Status of Government Grants 16 May 2022 9:22AM $2.280 $6.170 risen by 170.61%
$1,866 Oneview Litigation 14 Apr 2022 11:23AM $2.130 $6.170 risen by 189.67%
$1,866 ONE: Settlement of Legal Dispute with Regis 14 Apr 2022 9:55AM $2.130 $6.170 risen by 189.67%

151 - 175 of 389 results

Page 7 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.